Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
03/10/1998 | US5725854 Administering cells and immunology |
03/10/1998 | US5725768 Granulocyte removing apparatus |
03/06/1998 | CA2209890A1 Apoptotic agents for tumor cells of the nervous system |
03/05/1998 | WO1998008944A1 Novel bacteriophage, method for screening the same, novel biobactericidal materials prepared with the use of the same, and reagent for detecting the same |
03/05/1998 | WO1998008556A1 Method for removing tumor cells from tumor cell-contaminated stem cell products |
03/05/1998 | WO1998008542A2 Compounds and methods for treatment and diagnosis of mycobacterial infections |
03/05/1998 | WO1998008526A1 Method to obtain oestrogens from mare's urine |
03/05/1998 | WO1998008525A1 Process to obtain oestrogens from mare's urine |
03/05/1998 | WO1998002548A3 Infectious papillomavirus pseudoviral particles |
03/05/1998 | DE19729641A1 Antihämolytische liposomale Zubereitung und Verfahren zu deren Herstellung Antihemolytic liposomal preparation and methods for their preparation |
03/05/1998 | CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections |
03/05/1998 | CA2261612A1 Method for removing tumor cells from tumor cell-contaminated stem cell products |
03/04/1998 | EP0826966A2 Method for stabilizing platelets |
03/04/1998 | EP0826965A1 Method for producing a factor V depleted plasma |
03/04/1998 | EP0826775A1 Vector system for conditional gene expression |
03/04/1998 | EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase |
03/04/1998 | EP0826374A2 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
03/04/1998 | EP0826311A1 Oral composition for animals |
03/04/1998 | EP0826062A1 Hbv vectors and cells for producing the same |
03/04/1998 | EP0826051A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
03/04/1998 | EP0826045A1 Nucleic acids for treating obesity |
03/04/1998 | EP0826043A1 Methods for modulating t cell survival by modulating bcl-x l? protein level |
03/04/1998 | EP0826035A1 Isolating and culturing schwann cells |
03/04/1998 | EP0825998A1 Preparation of immunoglobulin |
03/04/1998 | EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
03/04/1998 | EP0825869A1 Pharmaceutical composition comprising lactobacillus plantarum and arginine |
03/04/1998 | EP0825868A1 Method of preventing or treating alimentary tract damage due to chemotherapy or radiation |
03/04/1998 | EP0825863A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
03/04/1998 | EP0542949B1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines |
03/04/1998 | CN1175214A Petide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
03/04/1998 | CN1174887A Health care and anti-senile wine and preparation method |
03/04/1998 | CN1174741A Traditional Chinese medicinal pill for curing osteonecrosis |
03/04/1998 | CN1174725A Process for brewing Wujie wine |
03/04/1998 | CN1174717A Traditional Chinese medicine for curing gastric disease |
03/04/1998 | CN1174711A Medicinal preparation for purpura |
03/04/1998 | CN1174706A Medicine and production method for curing bacteria infection, beautying and anti senility |
03/04/1998 | CN1174705A Medical preparation cantaining anti hemolytic blood-fat material |
03/03/1998 | US5723583 Antibody containing sialyl lewis X determinants |
03/03/1998 | US5723503 Biological treatment for rheumatoid arthritis |
03/03/1998 | US5723333 Vectors of oncogenes, promoters, transcription |
03/03/1998 | US5723331 Methods and compositions for the repair of articular cartilage defects in mammals |
03/03/1998 | US5723287 Retroviral particle comprising fusion protein and nucleic acid; genetic engineering |
03/03/1998 | US5723281 Plasma-like substance |
03/03/1998 | US5723127 Cancer therapy, vaccines; cell-mediated immune response enhancers |
02/28/1998 | CA2212954A1 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
02/26/1998 | WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
02/26/1998 | WO1998007436A1 Treatment of autoimmune diseases |
02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
02/26/1998 | WO1997044063A3 Dha-pharmaceutical agent conjugates |
02/26/1998 | CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
02/25/1998 | EP0825256A2 Hybrid cell and its use for the preparation of a drug for the induction of tumourimmunity |
02/25/1998 | EP0825255A1 Method of producing activated killer monocytes |
02/25/1998 | EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque |
02/25/1998 | EP0824594A1 Improved methods for transfecting t cells |
02/25/1998 | EP0824588A1 Il-6 activity inhibitor |
02/25/1998 | EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use |
02/25/1998 | EP0824352A1 Cyclodextrin compounds and methods of making and use thereof |
02/25/1998 | CN1174558A Tumor necrosis factor-Gamma |
02/25/1998 | CN1174515A Centrifuge reagent delivery system |
02/25/1998 | CN1174509A Gene transfer-mediated angiogenesis therapy |
02/25/1998 | CN1174508A Improvement in or relating to endometrial function |
02/25/1998 | CN1174506A Method of immunomodulation by means of adoptive transfer of antigernspecific cytotoxic T-cells |
02/25/1998 | CN1174493A Amelioration of human erectile dysfunction by treatment with iNOS, and related NOS agents |
02/25/1998 | CN1174081A 'Longteng' medicinal wine |
02/25/1998 | CN1174059A 'Xiaochuankangle' capsule for asthma |
02/25/1998 | CN1174054A Medicine for removing thrombus and promoting blood circulation and its preparation |
02/25/1998 | CN1174037A Monascus preparation for hyperlipemia and relevant cardiac and cerebral diseases |
02/25/1998 | CN1174036A Shark capsule and its preparation |
02/25/1998 | CN1174035A Antirheumatic capsule capable of controlling inflammation and skeleton deformation of rheumatoid disease |
02/25/1998 | CN1173989A Compounding process of food and drink seasoned with spirulina-active salt seasoning |
02/25/1998 | CN1037526C Method for producing kanglemycin C |
02/24/1998 | US5721354 For treatment of infections, medical diagnosis |
02/24/1998 | US5721215 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
02/24/1998 | US5721139 Culturing schwann cells in nutrient solution containing mitogenic agents |
02/24/1998 | US5721107 Antibodies to G protein coupled glutamate receptors |
02/24/1998 | US5720981 Aqueous cell-free extract of epidermal cells |
02/24/1998 | US5720957 Recombinant human cytomegalovirus vaccine |
02/24/1998 | US5720921 Flow electroporation chamber and method |
02/24/1998 | CA2002208C Extraction methods for preparing thromboplastin reagents |
02/19/1998 | WO1998006847A1 Human dbi/acbp-like protein |
02/19/1998 | WO1998006846A1 Human induced tumor protein |
02/19/1998 | WO1998006746A2 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
02/19/1998 | WO1998006445A1 Bladder submucosa seeded with cells for tissue reconstruction |
02/19/1998 | WO1998006441A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
02/19/1998 | WO1998006421A1 Therapeutic compositions for treatment of cancer |
02/19/1998 | WO1998006411A2 Use of lactobacillus gg in the rehydrating solution |
02/19/1998 | WO1998006408A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
02/19/1998 | WO1998006278A1 Methods and compositions for increasing the anaerobic working capacity in tissues |
02/19/1998 | WO1997044356A3 Ret ligand (retl) for stimulating neural and renal growth |
02/19/1998 | CA2263338A1 Therapeutic compositions for treatment of cancer |
02/19/1998 | CA2263316A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
02/19/1998 | CA2263169A1 Human dbi/acbp-like protein |
02/19/1998 | CA2263165A1 Human induced tumor protein |
02/19/1998 | CA2263144A1 Bladder submucosa seeded with cells for tissue reconstruction |
02/18/1998 | EP0824213A2 Method for fractionating red blood cells and antibacterial materials or bacterial proliferation inhibitors produced thereby |
02/18/1998 | CN1173877A Novel membrane proteins of helicobacter pylori |
02/18/1998 | CN1173375A Medicinal liquor and its prodn. method |
02/18/1998 | CN1173368A Medicine for treating child asthma type bronchitis |
02/18/1998 | CN1173366A Hypoglycemic high calcium granule and its prodn. |
02/18/1998 | CN1173365A Chinese medicinal preparation for curing rheumatism and rheumatoid disease and its prepn. method |